[Insulin resistance in type 2 diabetes as a microdomain syndrome].
Inokuchi
Jin-ici
JI
inokuchi@kinou02.pharm.hokudai.ac.jp
Igarashi
Yasuyuki
Y
D000818:Animals; D003924:Diabetes Mellitus, Type 2 / Q000209:etiology*; D005679:G(M3) Ganglioside / Q000502:physiology*; D006801:Humans; D007328:Insulin / Q000378:metabolism; D055504:Insulin Receptor Substrate Proteins; D007333:Insulin Resistance; D021962:Membrane Microdomains / Q000502:physiology*; D010750:Phosphoproteins / Q000378:metabolism; D011972:Receptor, Insulin / Q000378:metabolism; D015398:Signal Transduction / Q000502:physiology; D013577:Syndrome; D014409:Tumor Necrosis Factor-alpha / Q000502:physiology
D005679:G(M3) Ganglioside; C526292:IRS1 protein, human; D007328:Insulin; D055504:Insulin Receptor Substrate Proteins; D010750:Phosphoproteins; D014409:Tumor Necrosis Factor-alpha; D011972:Receptor, Insulin